Get the Stockscreener App
21.55
0.19%
0.035
Avadel Pharmaceuticals Plc stock is traded at $21.55, with a volume of 743.25K.
It is up +0.19% in the last 24 hours and down -0.14% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$21.51
Open:
$21.53
24h Volume:
743.25K
Relative Volume:
0.25
Market Cap:
$2.11B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
-652.88
EPS:
-0.033
Net Cash Flow:
$5.89M
1W Performance:
+0.33%
1M Performance:
-0.14%
6M Performance:
+91.90%
1Y Performance:
+169.38%
1-Day Range:
$21.50
$21.56
1-Week Range:
$21.48
$21.56
52-Week Range:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.55 | 2.11B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
124.05 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.97 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.65 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
470.62 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Form 8.3•Avadel Pharmaceuticals plc - The Manila Times
Understanding the Setup: (AVDL) and Scalable Risk - Stock Traders Daily
Avadel Sets Court Date for Alkermes Acquisition Scheme - TipRanks
Avadel Pharmaceuticals Announces Court Hearing for Acquisition - TradingView — Track All Markets
Avadel (NASDAQ: AVDL) moves Alkermes acquisition forward with Irish court hearing date - Stock Titan
State Street Increases Stake in Avadel Pharmaceuticals by 2.39% - Intellectia AI
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 2.39% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals - Investing.com India
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals - Investing.com India
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com India
UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.92% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 1.32% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley Capital Services discloses Avadel Pharmaceuticals dealings By Investing.com - Investing.com Nigeria
Avadel Pharmaceuticals shareholders approve $2.37B takeover bid - The Business Journals
Sentiment Review: Can Annovis Bio Inc disrupt its industryBond Market & Weekly Setup with High ROI Potential - baoquankhu1.vn
UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals - Investing.com India
BlackRock discloses 6.92% stake in Avadel Pharmaceuticals - Investing.com
Avadel Pharmaceuticals PLC. $AVDL Position Decreased by Wealth Effects LLC - MarketBeat
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com India
FIL Limited discloses 3.14% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.93% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Goldman Sachs Asset Management reduces stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 1.43% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.93% stake in Avadel Pharmaceuticals - Investing.com
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):